Companies / AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

NYSE: AIMCIK 946644OCALA, FL

Financials · FY2025

Revenue$88.0K
Net income$-13.96M
Total debt$5.71M
Cash$9.90M
Diluted EPS$-8.62
Shares outstanding30.4M

Ownership

30.4M shares outstanding · as of Aug 7, 2026
0.31%Insiders
Ownership
Insiders0.31%95,804
Institutions0.39%118,522
Public float99.30%30,227,813

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Equels Thomas KCEOCEO & President · Director
0.21%63,922
Chemerow David I.Director
0.10%31,882

Institutional holders 13

View all →
HolderValue% of shares
DRW Securities, LLC$78.6K0.23%
Vanguard Group Inc$19.8K0.06%
Geode Capital Management, LLC$17.5K0.10%
Morgan Stanley$976<0.01%
UBS Group AG$428<0.01%
Community Bank, N.A.$147<0.01%
Tower Research Capital LLC (TRC)$141<0.01%
Bank of America Corp /De$32<0.01%
Osaic Holdings, Inc.$16<0.01%
Hoey Investments, Inc$12<0.01%

Activity

Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$7.3K+13K
+72.18%
29,918
0.10% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$1+1
+3.70%
28
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AIMCommon StockEquity00901B303BBG000JL6Z80